Français

SESSION 1 (8:15AM - 11:30AM)

HPV AND HEAD AND NECK CANCER: EVOLVING CHANGES IN THE DISEASE

CATEGORY 1 CORE - 3 CE CREDITS

Course Outline:

A dramatic increase in the number of HPV-associated oropharynx cancers, particularly those of the tonsil and base of tongue, has captured the attention of the medical community worldwide. This session will focus on the changing landscape of head and neck cancers, the role the human papillomavirus (HPV) plays in these cancers, and clinical presentations of oral and oropharyngeal cancer, diagnoses of potentially malignant oral lesions and the dental professionals' role in early detection will also be presented.

Topics covered will include:

  • The changing epidemiology of head and neck cancers.
  • Clinical presentation, diagnosis, staging, treatment, and prognosis.
  • Management of oral complications of HPV-associated orophyarygeal cancer.

Learning Objectives:

At the end of the lecture, participants will:

  • Understand the current trends and changing epidemiology in HPV-positive head and neck cancer.
  • Recognize the clinical presentation of potentially malignant oral lesions and cancer, and present current and next-stage adjuncts for detection and mucosal lesions.
  • Review the natural history of oral HPV and who is at risk for these cancers.
  • Understand current standard of therapy, complications from therapy and controversies in therapy for patients with HPV-positive head and neck cancer.

SESSION 2 (12:30PM - 3:45PM)

IMMUNIZATION: A PANEL DISCUSSION

(WHAT WE KNOW, WHO WE CAN PROTECT, AND WHAT IS AVAILABLE)

CATEGORY 1 CORE - 3 CE CREDITS

Course Outline:

The HPV vaccine is effective in preventing HPV-related cancer and recent data suggests these vaccines also are effective against oral HPV infection. Yet the uptake of the HPV vaccine for those at risk (i.e. girls and boys) remains a challenge.

Topics covered will include:

  • HPV infection and transmission.
  • Strategies and challenges in preventing HPV-associated cancers.
  • Counselling and education.

Learning Objectives:

At the end of the lecture, participants will:

  • Understand HPV transmission - behavioural questions and answers.
  • Discuss global burder of HPV-related disease and rationale for needing HPV vaccination.
  • Review the data on the efficacy of the HPV vaccine
  • Discuss Canada's HPV vaccine policy, vaccine uptake, and barriers to vaccination.
  • How to break bad medical news (like oral cancer) to patients and make appropriate referrals.

Biographies:

Dr. Joel B. Epstein is Professor, Department of Surgery, Cedars-Sinai Medical Center, and a Collaborative member of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai. He is consulting staff in the Division of Otolaryngology and Head and Neck Surgery at the City of Hope National Medical Center. He maintains a referral oral medicine practice and is conducting a number of industry-funded clinical studies in the practice. Dr. Epstein graduated from the University of Saskatchewan in 1976. He completed a Certificate in Oral Medicine and Masters' of Science Degree in Dentistry from the University of Washington in Seattle in 1979. He is a Fellow of the College of Dental Surgeons of Canada in Oral Medicine/Oral Pathology, and a Certified Specialist in Oral Medicine in British Columbia. He is a fellow or the Royal College of Surgeons of Edinburgh and a Diplomat of the American Board of Oral Medicine. Dr. Epstein has published extensively in the area of oncology, infectious disease, facial pain and general areas of Oral Medicine, with more than 700 contributions to the literature.

Dr. Gypsyamber D'Souza is an Associate Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, with a joint appointment in the department of International Health and Otolaryngology-Head and Neck Surgery at the Johns Hopkins Sydney Kimmel Comprehensive Cancer Center. She has a M.S. in Molecular and cellular biology from the University of Wisconsin-Madison (1999), an MPH in Disease Control (2001) from the University of Texas-Houston, and a Phd in infectious disease epidemiology from Johns Hopkins (2007). Dr. D'Souza leads a research program on infectious causes of cancer, global cancer, screening and prevention of cancer, and risk reduction among high risk populations. Dr. D'Souza is a member of the NIH National Cancer Institute HPV Vaccine Trial Working Group, and the American Dental Association Council on Scientific Affairs Cancer and Debilitating Diseases Subcommittee. She is a recognized expert on oral HPV infectio and its role in head and neck cancer. She has over 100 publications and her research has been cited over 7,000 times.

Dr. Shao Hui (Sophie) Huang is an Assistant Professor in the Department of Radiation Oncology at the University of Toronto. She is an MD trained in China, and completed her Hons BSc in Radiation Therapy at the University of Toronto Michener Institute in 2003. Since graduation, she works as a radiation therapist at The Princess Margaret Cancer Centre. Dr. Huang currently divides her time between maintaining the Head and Neck Cancer Anthology of Outcomes System at the institution, coordinating the multi-disciplinary Head and Neck Cancer Conference, clinical and translational research, and delivering radiation treatment for head and neck cancers. She has been the principal investigator, co-investigator and research supervisor in many research projects and has more than 60 peer-reviewed publications. She was editorial board coodinator for UICC Manual of Clinical Oncology 9th Edition and the author of several book chapters. Her major interest is to understanding clinical behaviour, diagnosis and outcomes of HPV-related oropharyngeal cancer. She has received several research awards at international Scientific Meetings.

HPV and Head and Neck Cancer: Evolving Changes in the Disease AND Immunization: A Panel Discussion (What We Know, Who We Can Protect, and What is Available)

  • November 3, 2017
  • 200 Coventry Road
    Ottawa, Ontario
    Canada
    K1K 4S3